We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2020 13:31

RNS Number : 0578U
Midatech Pharma PLC
24 July 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Midatech Pharma PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

SPREADEX LTD

City and country of registered office (if applicable)

St Albans, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

21/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

24/07/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

Less than 3%

39,252,557

Position of previous notification (if

applicable)

3.82%

0.52%

4.34%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

SUBTOTAL 8. A

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

David Corben

01727895193

 

Place of completion

UK

Date of completion

24/07/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLRIMTTMTTTBLM
Date   Source Headline
16th Sep 20215:00 pmRNSOfficial Opening of New Cardiff Headquarters
17th Aug 20215:23 pmRNSChange of Registered Office
15th Jul 202110:28 amRNSGrant of Options and PDMR dealings
12th Jul 20212:30 pmRNSAppointment of Chief Scientific Officer
7th Jul 202111:21 amRNSHolding(s) in Company
30th Jun 202112:07 pmRNSResult of AGM
29th Jun 20217:00 amRNSUK Placing to Raise £10.0 million
18th Jun 20214:29 pmRNSHolding(s) in Company
17th Jun 20214:41 pmRNSSecond Price Monitoring Extn
17th Jun 20214:35 pmRNSPrice Monitoring Extension
17th Jun 20212:05 pmRNSSecond Price Monitoring Extn
17th Jun 20212:00 pmRNSPrice Monitoring Extension
17th Jun 202111:00 amRNSPrice Monitoring Extension
17th Jun 20217:00 amRNSBreakthrough data using Q-Sphera technology
9th Jun 20217:00 amRNSInvestor Webinar Scheduled for 17 June 2021
21st May 20213:56 pmRNSPosting of Annual Report & Notice of AGM
30th Apr 20212:05 pmRNSResults for the Year Ended 31 December 2020
25th Mar 20217:00 amRNSMTX110 Update & Headline Results for 2020
17th Feb 20217:00 amRNSExercise of Warrants and Issue of Equity
16th Feb 20215:46 pmRNSHolding(s) in Company
15th Feb 20214:12 pmRNSHolding(s) in Company
11th Feb 20216:20 pmRNSHolding(s) in Company - Replacement
11th Feb 20213:42 pmRNSHolding(s) in Company
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension
26th Jan 20212:06 pmRNSSecond Price Monitoring Extn
26th Jan 20212:01 pmRNSPrice Monitoring Extension
26th Jan 202110:30 amRNSBusiness Update
8th Jan 20214:40 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
11th Dec 20205:00 pmRNSMTX110 Programmes to be presented at ISPNO 2020
11th Dec 202010:00 amRNSLaunch of new website
9th Dec 20207:00 amRNSParliament Highlights Need for New DIPG Treatments
24th Nov 20207:00 amRNSMTX110 presented at 2020 Annual SNO Conference
19th Oct 20204:40 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
19th Oct 202011:06 amRNSSecond Price Monitoring Extn
19th Oct 202011:00 amRNSPrice Monitoring Extension
19th Oct 20207:00 amRNSHeadline Results of MTX110 Phase I DIPG Study
30th Sep 20205:54 pmRNSIssue of Equity for Employee Share Incentive Plan
23rd Sep 202011:42 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSHolding(s) in Company
10th Sep 20207:00 amRNSInterim results - 6 months ended 30 June 2020
7th Sep 20207:00 amRNSInvestor Webinar
28th Aug 20207:00 amRNSNotice of Interim Results
25th Aug 20202:51 pmRNSHolding(s) in Company
21st Aug 20202:06 pmRNSSecond Price Monitoring Extn
21st Aug 20202:00 pmRNSPrice Monitoring Extension
19th Aug 20207:00 amRNSExercise of Warrants and Issue of Equity
17th Aug 20205:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.